Will Smith Comes Out of the Psychedelic Closet
And it sounds like we’ll hear more about his psychedelic experiences on ayahuasca in his upcoming memoir, simply titled “Will.”
Entries by Greg Gilman
Why NeonMind Is Betting on Psilocybin to Curb the Global Obesity Epidemic
The psychedelic bioscience company’s top advisor tells Psychedelic Spotlight that psilocybin “affects at least the 5h2C receptor, which is dedicated towards appetite and appetite suppression.”
How Cybin Is ‘Revolutionizing’ Mental Healthcare with Novel Psychedelic Compounds
CEO Doug Drysdale explains several key factors in making psychedelic-assisted therapy accessible for the millions of people suffering around the globe.
Psychedelic Business Spotlight: September 24, 2021
This week in psychedelic business news: two patents may revolutionize the medical application of psychedelic compounds; DMT and ibogaine clinical trials show promise; and stock news for psychedelic investors.
‘Nine Perfect Strangers’ Director Calls Psychedelics a ‘Salvation of Humanity’
But the psychedelic community is concerned the Hulu series is full of “misinformation” about psychedelic-assisted therapy, and think the show may be harmful to the progressive movement.
Why Psychedelic Spotlight Is Taking the North Star Ethics Pledge
“We are committed to leveraging this pledge as a powerful guide and resource to help us earn trust and to never lose sight of our ability to help contribute to the greater good of humanity,” says our CEO David Flores.
Psychedelic Drug Use Among College Students Increased During Covid-19 Pandemic
Annual survey finds college students drank less during the pandemic, in favor of smoking more marijuana and experimenting with hallucinogens.
Ketamine One Partners with OVR Technology to Provide Scent-Enabled VR Psychedelic Experiences
Take a whiff of the latest development in virtual reality technology available to further immerse patients in psychedelic-assisted therapy.
I Drank a ‘Mushroom Latte’ Every Morning for Two Weeks: Here’s How I Felt
Everyday Dose is a tasty coffee replacement, which is easy to make and loaded with healthy benefits.
Why PsyBio Is Using Biosynthetic Psilocybin, Not Mushrooms, to Build Better Therapeutics
“A mushroom is not a pharmaceutical product,” CEO Evan Levine stresses, and explains why his company’s method of biologically engineering psilocybin is “cheaper, faster, greener.”
